请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00045
Application Flow cytometry, animal model study
Aliases B29, IGB, Ig-beta
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human CD79B
Formulation PBS, pH 7.4

Description

What is polatuzumab biosimilar research grade? Polatuzumab is a humanized IgG1-kappa monoclonal antibody against the human CD79B protein, which is ubiquitously expressed on the surface of malignant B cells. Polatuzumab vedotin is used to treat diffuse large B-cell lymphoma (DLBCL) after at least two other cancer treatments did not work or have stopped working. It is given in combination with bendamustine (Bendeka, Treanda) and a medicine that contains rituximab (Rituxan). Polatuzumab vedotin works by attaching to CD79b and releasing a toxic substance that kills the cancer cells. Polatuzumab biosimilar uses the same protein sequences as the therapeutic antibody polatuzumab.

Polatuzumab Biosimilar, Human CD79B Monoclonal Antibody B00045

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥1300

¥1300
加入购物车
立即购买
Polatuzumab Biosimilar, Human CD79B Monoclonal Antibody-远泰生物
请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00045
Application Flow cytometry, animal model study
Aliases B29, IGB, Ig-beta
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human CD79B
Formulation PBS, pH 7.4

Description

What is polatuzumab biosimilar research grade? Polatuzumab is a humanized IgG1-kappa monoclonal antibody against the human CD79B protein, which is ubiquitously expressed on the surface of malignant B cells. Polatuzumab vedotin is used to treat diffuse large B-cell lymphoma (DLBCL) after at least two other cancer treatments did not work or have stopped working. It is given in combination with bendamustine (Bendeka, Treanda) and a medicine that contains rituximab (Rituxan). Polatuzumab vedotin works by attaching to CD79b and releasing a toxic substance that kills the cancer cells. Polatuzumab biosimilar uses the same protein sequences as the therapeutic antibody polatuzumab.

Polatuzumab Biosimilar, Human CD79B Monoclonal Antibody B00045

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥1300

¥1300
加入购物车
立即购买